+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biologics & Biosimilars CXO Services Market - Global Forecast 2025-2030- Product Image
Biologics & Biosimilars CXO Services Market - Global Forecast 2025-2030- Product Image
Sale

Biologics & Biosimilars CXO Services Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6079859
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Biologics and biosimilars are redefining pharmaceutical development, driving the demand for highly specialized CXO services that navigate evolving regulatory, technological, and operational landscapes. These advanced therapies require integrated expertise to accelerate product development and optimize value throughout the life cycle.

Market Snapshot: Biologics and Biosimilars CXO Services

The biologics and biosimilars CXO services market is experiencing robust growth, propelled by breakthrough molecules and expanding therapeutic pipelines. Innovative engagement models, rising demand for digital integration, and a shifting regulatory climate position this sector at the forefront of pharmaceutical outsourcing. As healthcare systems prioritize access to novel and cost-effective therapeutics, strategic service partners play a pivotal role in translating scientific innovation into commercial success.

Scope & Segmentation

This report provides in-depth analysis across multiple dimensions, outlining major segments, regional markets, and enabling technologies that shape the CXO services landscape for biologics and biosimilars.

  • Service Types: Commercialization services, digital transformation solutions including AI analytics and cloud integration, contract manufacturing, pharmacovigilance, R&D, regulatory support, strategy consulting, and supply chain optimization.
  • Therapeutic Focus Areas: Cardiovascular (including atherosclerosis, heart failure), endocrinology (diabetes, hormonal disorders), immunology (autoimmune, inflammatory), neurology (CNS and neurodegenerative diseases), oncology (hematologic, solid tumors), rare and genetic diseases, and orphan indications.
  • End User Segments: Academic and research institutes, universities, full-spectrum and niche contract research organizations, large and mid-sized pharmaceutical companies, and biotechs of varying scale.
  • Deployment Models: Cloud-based platforms, hybrid infrastructures, and on-premises solutions, each catering to distinct data integration and security needs.
  • Engagement Models: Outcome-based contracts with performance and risk-sharing agreements, project-based arrangements, as well as annual and monthly subscription tiers.
  • Regional Analysis: Americas (including United States regions such as California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio, plus Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, Netherlands, Switzerland, and others), Asia-Pacific (China, India, Japan, South Korea, Australia, Singapore, and additional markets).
  • Company Coverage: Profiles and developments of leading players such as Lonza Group AG, Thermo Fisher Scientific, Catalent, Samsung BioLogics, WuXi Biologics, Boehringer Ingelheim, AGC Biologics, FUJIFILM Diosynth, Recipharm AB, and Charles River Laboratories.

Key Takeaways for Decision-Makers

  • Integrated CXO providers with regulatory and digital transformation expertise are best positioned to accelerate development timelines and manage compliance milestones across diverse markets.
  • Evolving regulatory harmonization and digital tools are altering the approach to target validation and patient enrollment, prompting realignment of service offerings.
  • Outcome-based contract models are gaining traction, linking service fees to clinical or commercial milestones and placing an emphasis on performance-driven partnerships.
  • Comprehensive service coverage, including pharmacovigilance and supply chain management, is increasingly essential for maintaining product quality and lifecycle value.
  • Collaborative networks with academic, technology, and supply chain partners are enhancing trial design, biomarker discovery, and post-approval evidence generation.

Tariff Impact: United States Changes and Global Supply Chains

Forthcoming United States tariff adjustments scheduled for 2025 introduce multi-layered risk factors for biologics and biosimilars development. Rising costs for imported raw materials and reagents are prompting sponsors to reassess supplier strategies. Contract manufacturing organizations are investing in localized production and diversified procurement to sustain supply continuity. These dynamics are accelerating the move toward vertically integrated service models and resilience-focused networks across the CXO ecosystem.

Methodology & Data Sources

The findings are grounded in a rigorous approach integrating primary interviews with senior decision-makers from pharma, biotech, and services, alongside secondary research from regulatory filings and peer-reviewed industry literature. Insights are validated through quantitative and qualitative triangulation with experts in clinical research, supply chain, and regulatory affairs.

Why This Report Matters

  • Equips leaders with detailed strategic frameworks for vendor evaluation and partnership structuring in biologics and biosimilars CXO services.
  • Delivers insights into managing risk, expediting market entry, and enhancing supply chain robustness through integrated solutions and digital innovation.
  • Enables executives to anticipate tariff-related challenges and align with evolving regulatory trajectories for global success.

Conclusion

With its thorough segmentation analysis, regional insights, and actionable recommendations, this report serves as an essential resource for advancing your biologics and biosimilars CXO strategy. Leverage its guidance to make timely, informed decisions in an increasingly complex and dynamic market.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of continuous bioprocessing and real-time analytics to enhance biosimilar manufacturing efficiency
5.2. Deployment of single-use bioreactor technologies for scalable and contamination-reduced biologics production
5.3. Utilization of artificial intelligence and machine learning for predictive process control in cell culture
5.4. Expansion of end-to-end biosimilar development partnerships encompassing clinical, regulatory, and manufacturing support
5.5. Adoption of modular and flexible facility designs to accelerate time-to-market for novel biologics programs
5.6. Implementation of digital twin technology for comprehensive process monitoring and risk mitigation in bioproduction
5.7. Growing demand for high-throughput cell line screening platforms to shorten biologics candidate selection timelines
5.8. Strategic outsourcing of post-approval lifecycle management and pharmacovigilance services for biosimilar portfolios
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biologics & Biosimilars CXO Services Market, by Service Type
8.1. Introduction
8.2. Commercialization Services
8.2.1. Launch Planning
8.2.2. Marketing
8.2.3. Medical Affairs
8.3. Digital Transformation Services
8.3.1. AI Analytics
8.3.2. Cloud Integration
8.3.3. Digital Twin Development
8.4. Manufacturing Services
8.4.1. Contract Manufacturing
8.4.2. Process Development
8.4.3. Scale-Up
8.4.4. Technology Transfer
8.5. Pharmacovigilance Services
8.5.1. Case Processing
8.5.2. Risk Management
8.5.3. Signal Detection
8.6. R&D Services
8.6.1. Biomarker Development
8.6.2. Clinical Trial Management
8.6.3. Preclinical Studies
8.7. Regulatory Services
8.7.1. Bla/Nda Support
8.7.2. Ind Submissions
8.7.3. Post-Market Surveillance
8.8. Strategy Consulting Services
8.8.1. Business Strategy Development
8.8.2. Market Assessment
8.8.3. Portfolio Optimization
8.9. Supply Chain Services
8.9.1. Cold Chain Management
8.9.2. Logistics Optimization
8.9.3. Warehouse Management
9. Biologics & Biosimilars CXO Services Market, by Therapeutic Area
9.1. Introduction
9.2. Cardiovascular
9.2.1. Atherosclerosis
9.2.2. Heart Failure
9.3. Endocrinology
9.3.1. Diabetes
9.3.2. Hormonal Disorders
9.4. Immunology
9.4.1. Autoimmune Disorders
9.4.2. Inflammatory Disorders
9.5. Neurology
9.5.1. CNS Disorders
9.5.2. Neurodegenerative Diseases
9.6. Oncology
9.6.1. Hematologic Malignancies
9.6.2. Solid Tumors
9.7. Rare Diseases
9.7.1. Genetic Disorders
9.7.2. Orphan Conditions
10. Biologics & Biosimilars CXO Services Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.2.1. Research Hospitals
10.2.2. Universities
10.3. Biotech Firms
10.3.1. Large Biotech
10.3.2. Small & Medium Biotech
10.4. Contract Research Organizations
10.4.1. Full-Service CROs
10.4.2. Niche CROs
10.5. Pharmaceutical Companies
10.5.1. Large Pharma
10.5.2. Mid-Sized Pharma
11. Biologics & Biosimilars CXO Services Market, by Deployment Model
11.1. Introduction
11.2. Cloud
11.3. Hybrid
11.4. On-Premises
12. Biologics & Biosimilars CXO Services Market, by Engagement Model
12.1. Introduction
12.2. Outcome-Based
12.2.1. Performance-Based Contracts
12.2.2. Risk-Sharing Agreements
12.3. Project-Based
12.3.1. Fixed Price Projects
12.3.2. Time & Material Projects
12.4. Subscription-Based
12.4.1. Annual Subscription
12.4.2. Monthly Subscription
13. Americas Biologics & Biosimilars CXO Services Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Biologics & Biosimilars CXO Services Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Biologics & Biosimilars CXO Services Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Lonza Group AG
16.3.2. Thermo Fisher Scientific, Inc.
16.3.3. Catalent, Inc.
16.3.4. Samsung BioLogics Co., Ltd.
16.3.5. WuXi Biologics (Cayman) Inc.
16.3.6. Boehringer Ingelheim International GmbH
16.3.7. AGC Biologics, Inc.
16.3.8. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
16.3.9. Recipharm AB
16.3.10. Charles River Laboratories International, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY DEPLOYMENT MODEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY DEPLOYMENT MODEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ENGAGEMENT MODEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ENGAGEMENT MODEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET: RESEARCHAI
FIGURE 26. BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET: RESEARCHSTATISTICS
FIGURE 27. BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET: RESEARCHCONTACTS
FIGURE 28. BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY COMMERCIALIZATION SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY COMMERCIALIZATION SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY LAUNCH PLANNING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY LAUNCH PLANNING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MARKETING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MARKETING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MEDICAL AFFAIRS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MEDICAL AFFAIRS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY COMMERCIALIZATION SERVICES, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY COMMERCIALIZATION SERVICES, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY DIGITAL TRANSFORMATION SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY DIGITAL TRANSFORMATION SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY AI ANALYTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY AI ANALYTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CLOUD INTEGRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CLOUD INTEGRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY DIGITAL TWIN DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY DIGITAL TWIN DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY DIGITAL TRANSFORMATION SERVICES, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY DIGITAL TRANSFORMATION SERVICES, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CONTRACT MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CONTRACT MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SCALE-UP, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SCALE-UP, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY TECHNOLOGY TRANSFER, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY TECHNOLOGY TRANSFER, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PHARMACOVIGILANCE SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PHARMACOVIGILANCE SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CASE PROCESSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CASE PROCESSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY RISK MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY RISK MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SIGNAL DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SIGNAL DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PHARMACOVIGILANCE SERVICES, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PHARMACOVIGILANCE SERVICES, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY R&D SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY R&D SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY BIOMARKER DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY BIOMARKER DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PRECLINICAL STUDIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PRECLINICAL STUDIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY R&D SERVICES, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY R&D SERVICES, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY REGULATORY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY REGULATORY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY BLA/NDA SUPPORT, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY BLA/NDA SUPPORT, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY IND SUBMISSIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY IND SUBMISSIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY POST-MARKET SURVEILLANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY POST-MARKET SURVEILLANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY REGULATORY SERVICES, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY REGULATORY SERVICES, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY STRATEGY CONSULTING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY STRATEGY CONSULTING SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY BUSINESS STRATEGY DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY BUSINESS STRATEGY DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MARKET ASSESSMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MARKET ASSESSMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PORTFOLIO OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PORTFOLIO OPTIMIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY STRATEGY CONSULTING SERVICES, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY STRATEGY CONSULTING SERVICES, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SUPPLY CHAIN SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SUPPLY CHAIN SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY COLD CHAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY COLD CHAIN MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY LOGISTICS OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY LOGISTICS OPTIMIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY WAREHOUSE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY WAREHOUSE MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SUPPLY CHAIN SERVICES, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SUPPLY CHAIN SERVICES, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ATHEROSCLEROSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ATHEROSCLEROSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY HEART FAILURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY DIABETES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY DIABETES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY HORMONAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY HORMONAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ENDOCRINOLOGY, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ENDOCRINOLOGY, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY INFLAMMATORY DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY INFLAMMATORY DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CNS DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CNS DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SOLID TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY RARE DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ORPHAN CONDITIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ORPHAN CONDITIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY RESEARCH HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY RESEARCH HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY UNIVERSITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 153. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY BIOTECH FIRMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY BIOTECH FIRMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 155. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY LARGE BIOTECH, BY REGION, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY LARGE BIOTECH, BY REGION, 2025-2030 (USD MILLION)
TABLE 157. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SMALL & MEDIUM BIOTECH, BY REGION, 2018-2024 (USD MILLION)
TABLE 158. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SMALL & MEDIUM BIOTECH, BY REGION, 2025-2030 (USD MILLION)
TABLE 159. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY BIOTECH FIRMS, 2018-2024 (USD MILLION)
TABLE 160. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY BIOTECH FIRMS, 2025-2030 (USD MILLION)
TABLE 161. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 162. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 163. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY FULL-SERVICE CROS, BY REGION, 2018-2024 (USD MILLION)
TABLE 164. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY FULL-SERVICE CROS, BY REGION, 2025-2030 (USD MILLION)
TABLE 165. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY NICHE CROS, BY REGION, 2018-2024 (USD MILLION)
TABLE 166. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY NICHE CROS, BY REGION, 2025-2030 (USD MILLION)
TABLE 167. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 168. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 169. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 170. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 171. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY LARGE PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 172. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY LARGE PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 173. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MID-SIZED PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 174. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MID-SIZED PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 175. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 176. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 177. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2024 (USD MILLION)
TABLE 178. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY DEPLOYMENT MODEL, 2025-2030 (USD MILLION)
TABLE 179. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 180. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 181. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY HYBRID, BY REGION, 2018-2024 (USD MILLION)
TABLE 182. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY HYBRID, BY REGION, 2025-2030 (USD MILLION)
TABLE 183. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ON-PREMISES, BY REGION, 2018-2024 (USD MILLION)
TABLE 184. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ON-PREMISES, BY REGION, 2025-2030 (USD MILLION)
TABLE 185. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ENGAGEMENT MODEL, 2018-2024 (USD MILLION)
TABLE 186. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ENGAGEMENT MODEL, 2025-2030 (USD MILLION)
TABLE 187. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY OUTCOME-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 188. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY OUTCOME-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 189. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PERFORMANCE-BASED CONTRACTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 190. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PERFORMANCE-BASED CONTRACTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 191. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY RISK-SHARING AGREEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 192. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY RISK-SHARING AGREEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 193. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY OUTCOME-BASED, 2018-2024 (USD MILLION)
TABLE 194. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY OUTCOME-BASED, 2025-2030 (USD MILLION)
TABLE 195. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PROJECT-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 196. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PROJECT-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 197. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY FIXED PRICE PROJECTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 198. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY FIXED PRICE PROJECTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 199. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY TIME & MATERIAL PROJECTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 200. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY TIME & MATERIAL PROJECTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 201. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PROJECT-BASED, 2018-2024 (USD MILLION)
TABLE 202. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PROJECT-BASED, 2025-2030 (USD MILLION)
TABLE 203. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SUBSCRIPTION-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 204. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SUBSCRIPTION-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 205. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ANNUAL SUBSCRIPTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 206. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ANNUAL SUBSCRIPTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 207. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MONTHLY SUBSCRIPTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 208. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MONTHLY SUBSCRIPTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 209. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SUBSCRIPTION-BASED, 2018-2024 (USD MILLION)
TABLE 210. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SUBSCRIPTION-BASED, 2025-2030 (USD MILLION)
TABLE 211. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 212. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 213. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY COMMERCIALIZATION SERVICES, 2018-2024 (USD MILLION)
TABLE 214. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY COMMERCIALIZATION SERVICES, 2025-2030 (USD MILLION)
TABLE 215. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY DIGITAL TRANSFORMATION SERVICES, 2018-2024 (USD MILLION)
TABLE 216. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY DIGITAL TRANSFORMATION SERVICES, 2025-2030 (USD MILLION)
TABLE 217. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 218. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 219. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PHARMACOVIGILANCE SERVICES, 2018-2024 (USD MILLION)
TABLE 220. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PHARMACOVIGILANCE SERVICES, 2025-2030 (USD MILLION)
TABLE 221. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY R&D SERVICES, 2018-2024 (USD MILLION)
TABLE 222. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY R&D SERVICES, 2025-2030 (USD MILLION)
TABLE 223. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY REGULATORY SERVICES, 2018-2024 (USD MILLION)
TABLE 224. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY REGULATORY SERVICES, 2025-2030 (USD MILLION)
TABLE 225. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY STRATEGY CONSULTING SERVICES, 2018-2024 (USD MILLION)
TABLE 226. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY STRATEGY CONSULTING SERVICES, 2025-2030 (USD MILLION)
TABLE 227. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SUPPLY CHAIN SERVICES, 2018-2024 (USD MILLION)
TABLE 228. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SUPPLY CHAIN SERVICES, 2025-2030 (USD MILLION)
TABLE 229. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 230. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 231. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 232. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 233. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ENDOCRINOLOGY, 2018-2024 (USD MILLION)
TABLE 234. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ENDOCRINOLOGY, 2025-2030 (USD MILLION)
TABLE 235. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
TABLE 236. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
TABLE 237. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 238. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 239. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 240. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 241. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 242. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 243. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 246. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 247. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY BIOTECH FIRMS, 2018-2024 (USD MILLION)
TABLE 248. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY BIOTECH FIRMS, 2025-2030 (USD MILLION)
TABLE 249. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 250. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 251. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 252. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 253. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2024 (USD MILLION)
TABLE 254. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY DEPLOYMENT MODEL, 2025-2030 (USD MILLION)
TABLE 255. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ENGAGEMENT MODEL, 2018-2024 (USD MILLION)
TABLE 256. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ENGAGEMENT MODEL, 2025-2030 (USD MILLION)
TABLE 257. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY OUTCOME-BASED, 2018-2024 (USD MILLION)
TABLE 258. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY OUTCOME-BASED, 2025-2030 (USD MILLION)
TABLE 259. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PROJECT-BASED, 2018-2024 (USD MILLION)
TABLE 260. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PROJECT-BASED, 2025-2030 (USD MILLION)
TABLE 261. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SUBSCRIPTION-BASED, 2018-2024 (USD MILLION)
TABLE 262. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SUBSCRIPTION-BASED, 2025-2030 (USD MILLION)
TABLE 263. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 264. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 265. UNITED STATES BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 266. UNITED STATES BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 267. UNITED STATES BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY COMMERCIALIZATION SERVICES, 2018-2024 (USD MILLION)
TABLE 268. UNITED STATES BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY COMMERCIALIZATION SERVICES, 2025-2030 (USD MILLION)
TABLE 269. UNITED STATES BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY DIGITAL TRANSFORMATION SERVICES, 2018-2024 (USD MILLION)
TABLE 270. UNITED STATES BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY DIGITAL TRANSFORMATION SERVICES, 2025-2030 (USD MILLION)
TABLE 271. UNITED STATES BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 272. UNITED STATES BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 273. UN

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Biologics & Biosimilars CXO Services market report include:
  • Lonza Group AG
  • Thermo Fisher Scientific, Inc.
  • Catalent, Inc.
  • Samsung BioLogics Co., Ltd.
  • WuXi Biologics (Cayman) Inc.
  • Boehringer Ingelheim International GmbH
  • AGC Biologics, Inc.
  • FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
  • Recipharm AB
  • Charles River Laboratories International, Inc.

Related Topics

Related Reports

Biologics CXO Services Market - Global Forecast 2025-2030 - Product Image

Biologics CXO Services Market - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Biosimilars Market by Drug Class (mAbs (Adalimumab, Infliximab, Rituximab, Trastuzumab), GCSF, Insulin, Anticoagulant, rhGH, Teriparatide, GLP-1), Indication (Oncology, Autoimmune, Diabetes, Obesity), Competitive Landscape, Region - Global Forecast to 2035 - Product Image

Biosimilars Market by Drug Class (mAbs (Adalimumab, Infliximab, Rituximab, Trastuzumab), GCSF, Insulin, Anticoagulant, rhGH, Teriparatide, GLP-1), Indication (Oncology, Autoimmune, Diabetes, Obesity), Competitive Landscape, Region - Global Forecast to 2035

  • Report
  • 392 Pages
  • Global
From
Biosimilars Market Industry Trends and Global Forecasts to 2035 - Distribution by Drug Class, Therapeutic Area, Type of Manufacturer, Distribution Channel, Geographical Regions and Leading Players - Product Image

Biosimilars Market Industry Trends and Global Forecasts to 2035 - Distribution by Drug Class, Therapeutic Area, Type of Manufacturer, Distribution Channel, Geographical Regions and Leading Players

  • Report
  • 319 Pages
  • Global
From
Biosimilars Market Overview, 2025-30 - Product Image

Biosimilars Market Overview, 2025-30

  • Report
  • 102 Pages
  • Global
From
Biosimilars Market - Global Forecast 2025-2030 - Product Image

Biosimilars Market - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.